{"id":"NCT01563081","sponsor":"GlaxoSmithKline","briefTitle":"Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics","officialTitle":"A Multi-Center, Open-labelled Study to Evaluate the Safety of Levocetirizine Hydrochloride Oral Solution in Children Aged 6 Months to 2 Years With Allergic Rhinitis or Pruritus Associated With the Skin Diseases.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-04","primaryCompletion":"2012-08","completion":"2012-08","firstPosted":"2012-03-26","resultsPosted":"2013-06-03","lastUpdate":"2017-02-28"},"enrollment":60,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Rhinitis"],"interventions":[{"type":"DRUG","name":"Levocetirizine","otherNames":[]},{"type":"DRUG","name":"Levocetirizine","otherNames":[]}],"arms":[{"label":"Levocetirizine","type":"EXPERIMENTAL"}],"summary":"To evaluate the safety of treatment with levocetirizine oral solution in pediatric patients aged form 6 months to 2 years old with allergic rhinitis or pruritus associated with the skin diseases.","primaryOutcome":{"measure":"Number of Participants With Serious Adverse Events (SAEs) and Non-serious Adverse Events (AEs)","timeFrame":"up to Week 2/Early Withdrawal (EW)","effectByArm":[{"arm":"Levocetirizine: >=6 Months and <12 Months Old","deltaMin":15,"sd":null},{"arm":"Levocetirizine: >=12 Months and <24 Months Old","deltaMin":17,"sd":null},{"arm":"Levocetirizine: Total Population","deltaMin":32,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":17},"locations":{"siteCount":7,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":["Nasopharyngitis","Diarrhoea","Gastroenteritis","Pharyngeal erythema","Eczema"]}}